Update on percutaneous transluminal coronary angioplasty and CABG

Area of Science:

• Cardiovascular medicine
• Interventional cardiology
• Cardiac surgery

Background:

• Percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) have evolved significantly over the last decade.
• PTCA has seen remarkable growth, now representing approximately 50% of revascularisation procedures at Royal Perth Hospital.
• Coronary surgery has experienced less growth but is now applied to older, high-risk patient populations with stable mortality rates.

Purpose of the Study:

• To analyze the recent trends and changes in PTCA and CABG procedures.
• To evaluate the expanding role of CABG in high-risk and elderly patients.
• To assess the outcomes and safety of these revascularisation techniques.

Main Methods:

• Retrospective analysis of revascularisation procedures performed over the past decade.
• Comparison of procedural volumes and patient demographics for PTCA and CABG.
• Outcome assessment for elderly and high-risk patients undergoing CABG.

Main Results:

• PTCA has become a dominant revascularisation strategy, accounting for 50% of procedures at Royal Perth Hospital.
• CABG utilization has shown less growth but has expanded to include a higher proportion of elderly and high-risk individuals.
• The application of CABG in these complex patient groups has been achieved without a significant increase in mortality.

Conclusions:

• PTCA is now a primary method for coronary revascularisation.
• CABG remains a viable and safe option for complex and high-risk patients, including the elderly.
• Both PTCA and CABG continue to be essential, evolving treatments for coronary artery disease.